... cirrhosis (n = 30/78, 38.5%), mostly intrahepatic (n = 25/30, 83.5%). This confirms the increasing incidence of intrahepatic localization and the epidemiological link recently reported between intrahepatic biliary tract carcinoma and cirrhosis. This was a retrospective analysis concerning 78 patients who...

...) with or without fibrosis. Nonalcoholic steatohepatitis evolves to cirrhosis in more than 20% of patients [ 2 ], and is currently considered to be a major cause of cryptogenic cirrhosis [ 3 ]. Nonalcoholic fatty liver disease is a clinicopathological entity with histological and biological characteristics...

...Markus Ruhnke; Matthias Trautmann; Klaus Borner; Walter Hopfenmüller The pharmacokinetics of ciprofloxacin were evaluated in 11 patients (3 patients with impaired renal function) with advanced liver cirrhosis after a single oral dose of 500 mg. Mean serum peaks were 2.80 ± 1.00 mg/l in 64 ± 37 min...

...P.A. Miglioli; P. Pivetta; R. Orlando; P. Palatini; A. Varotto; L. Okolicsanyi The pharmacokinetics of miocamycin, a new macrolide antibiotic, was studied in 6 healthy controls and 6 patients with compensated liver cirrhosis. The results indicate that in chronic liver disease the kinetics...